These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 28264096)
1. Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease. Gaiani A; Martinelli I; Bello L; Querin G; Puthenparampil M; Ruggero S; Toffanin E; Cagnin A; Briani C; Pegoraro E; Sorarù G JAMA Neurol; 2017 May; 74(5):525-532. PubMed ID: 28264096 [TBL] [Abstract][Full Text] [Related]
2. Significance of CSF NfL and tau in ALS. Schreiber S; Spotorno N; Schreiber F; Acosta-Cabronero J; Kaufmann J; Machts J; Debska-Vielhaber G; Garz C; Bittner D; Hensiek N; Dengler R; Petri S; Nestor PJ; Vielhaber S J Neurol; 2018 Nov; 265(11):2633-2645. PubMed ID: 30187162 [TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid and blood neurofilament light chain levels in amyotrophic lateral sclerosis and frontotemporal degeneration: A meta-analysis. Verde F; Licaj S; Soranna D; Ticozzi N; Silani V; Zambon A Eur J Neurol; 2024 Sep; 31(9):e16371. PubMed ID: 38937912 [TBL] [Abstract][Full Text] [Related]
4. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders. Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027 [TBL] [Abstract][Full Text] [Related]
5. CSF sAPPβ, YKL-40, and NfL along the ALS-FTD spectrum. Illán-Gala I; Alcolea D; Montal V; Dols-Icardo O; Muñoz L; de Luna N; Turón-Sans J; Cortés-Vicente E; Sánchez-Saudinós MB; Subirana A; Sala I; Blesa R; Clarimón J; Fortea J; Rojas-García R; Lleó A Neurology; 2018 Oct; 91(17):e1619-e1628. PubMed ID: 30291183 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis. Abu-Rumeileh S; Vacchiano V; Zenesini C; Polischi B; de Pasqua S; Fileccia E; Mammana A; Di Stasi V; Capellari S; Salvi F; Liguori R; Parchi P; J Neurol; 2020 Jun; 267(6):1699-1708. PubMed ID: 32100123 [TBL] [Abstract][Full Text] [Related]
7. Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease. Poesen K; De Schaepdryver M; Stubendorff B; Gille B; Muckova P; Wendler S; Prell T; Ringer TM; Rhode H; Stevens O; Claeys KG; Couwelier G; D'Hondt A; Lamaire N; Tilkin P; Van Reijen D; Gourmaud S; Fedtke N; Heiling B; Rumpel M; Rödiger A; Gunkel A; Witte OW; Paquet C; Vandenberghe R; Grosskreutz J; Van Damme P Neurology; 2017 Jun; 88(24):2302-2309. PubMed ID: 28500227 [TBL] [Abstract][Full Text] [Related]
8. Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis. Lu CH; Macdonald-Wallis C; Gray E; Pearce N; Petzold A; Norgren N; Giovannoni G; Fratta P; Sidle K; Fish M; Orrell R; Howard R; Talbot K; Greensmith L; Kuhle J; Turner MR; Malaspina A Neurology; 2015 Jun; 84(22):2247-57. PubMed ID: 25934855 [TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study. Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic value of CSF neurofilaments in a cohort of patients with motor neuron disease: A cross-sectional study. Gagliardi D; Faravelli I; Meneri M; Saccomanno D; Govoni A; Magri F; Ricci G; Siciliano G; Pietro Comi G; Corti S J Cell Mol Med; 2021 Apr; 25(8):3765-3771. PubMed ID: 33609080 [TBL] [Abstract][Full Text] [Related]
11. Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis. Gille B; De Schaepdryver M; Goossens J; Dedeene L; De Vocht J; Oldoni E; Goris A; Van Den Bosch L; Depreitere B; Claeys KG; Tournoy J; Van Damme P; Poesen K Neuropathol Appl Neurobiol; 2019 Apr; 45(3):291-304. PubMed ID: 29908069 [TBL] [Abstract][Full Text] [Related]
12. Neurofilaments in Sporadic and Familial Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis. Shahim P; Norato G; Sinaii N; Zetterberg H; Blennow K; Chan L; Grunseich C Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674431 [TBL] [Abstract][Full Text] [Related]
13. Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis. Falzone YM; Domi T; Mandelli A; Pozzi L; Schito P; Russo T; Barbieri A; Fazio R; Volontè MA; Magnani G; Del Carro U; Carrera P; Malaspina A; Agosta F; Quattrini A; Furlan R; Filippi M; Riva N Eur J Neurol; 2022 Jul; 29(7):1930-1939. PubMed ID: 35263489 [TBL] [Abstract][Full Text] [Related]
14. Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS. Halbgebauer S; Steinacker P; Verde F; Weishaupt J; Oeckl P; von Arnim C; Dorst J; Feneberg E; Mayer B; Rosenbohm A; Silani V; Ludolph AC; Otto M J Neurol Neurosurg Psychiatry; 2022 Jan; 93(1):68-74. PubMed ID: 34417339 [TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival. Skillbäck T; Mattsson N; Blennow K; Zetterberg H Amyotroph Lateral Scler Frontotemporal Degener; 2017 Aug; 18(5-6):397-403. PubMed ID: 28631955 [TBL] [Abstract][Full Text] [Related]
16. Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum. Meeter LHH; Vijverberg EG; Del Campo M; Rozemuller AJM; Donker Kaat L; de Jong FJ; van der Flier WM; Teunissen CE; van Swieten JC; Pijnenburg YAL Neurology; 2018 Apr; 90(14):e1231-e1239. PubMed ID: 29514947 [TBL] [Abstract][Full Text] [Related]
17. Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Verde F; Otto M; Silani V Front Neurosci; 2021; 15():679199. PubMed ID: 34234641 [TBL] [Abstract][Full Text] [Related]
18. Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression. Tortelli R; Ruggieri M; Cortese R; D'Errico E; Capozzo R; Leo A; Mastrapasqua M; Zoccolella S; Leante R; Livrea P; Logroscino G; Simone IL Eur J Neurol; 2012 Dec; 19(12):1561-7. PubMed ID: 22680408 [TBL] [Abstract][Full Text] [Related]
19. Distinguishing Frontotemporal Lobar Degeneration Tau From TDP-43 Using Plasma Biomarkers. Cousins KAQ; Shaw LM; Chen-Plotkin A; Wolk DA; Van Deerlin VM; Lee EB; McMillan CT; Grossman M; Irwin DJ JAMA Neurol; 2022 Nov; 79(11):1155-1164. PubMed ID: 36215050 [TBL] [Abstract][Full Text] [Related]
20. Serum neurofilament light chain in distinct phenotypes of amyotrophic lateral sclerosis: A longitudinal, multicenter study. Meyer T; Dreger M; Grehl T; Weyen U; Kettemann D; Weydt P; Günther R; Lingor P; Petri S; Koch JC; Großkreutz J; Rödiger A; Baum P; Hermann A; Prudlo J; Boentert M; Weishaupt JH; Löscher WN; Dorst J; Koc Y; Bernsen S; Cordts I; Vidovic M; Steinbach R; Metelmann M; Kleinveld VE; Norden J; Ludolph A; Walter B; Schumann P; Münch C; Körtvélyessy P; Maier A Eur J Neurol; 2024 Sep; 31(9):e16379. PubMed ID: 38859579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]